Management of different cardiovascular risk factors with a combination tablet (polypill)

P. Bramlage, W. Marz, D. Westermann, B. Weisser, J. H. Wirtz, U. Zeymer, P. Baumgart, G. van Mark, U. Laufs, B. K. Kramer, T. Unger

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionManagement of different cardiovascular risk factors with a combination tablet (polypill)
Original languageGerman
Pages (from-to)246-257
Number of pages12
JournalHerz
Volume43
Issue number3
DOIs
Publication statusPublished - 1 May 2018

Keywords

  • Cardiovascular prevention
  • Polypill
  • LDL cholesterol
  • Systolic blood pressure
  • Platelet aggregation inhibitors
  • RANDOMIZED CONTROLLED-TRIAL
  • PRESSURE-LOWERING DRUGS
  • BLOOD-PRESSURE
  • DISEASE PREVENTION
  • MEDICATION ADHERENCE
  • COST-EFFECTIVENESS
  • IMPROVE ADHERENCE
  • INDIAN POLYCAP
  • HEART-DISEASE
  • PRIMARY-CARE

Cite this

Bramlage, P., Marz, W., Westermann, D., Weisser, B., Wirtz, J. H., Zeymer, U., Baumgart, P., van Mark, G., Laufs, U., Kramer, B. K., & Unger, T. (2018). Management verschiedener kardiovaskulärer Risikofaktoren mit einem Kombinationspräparat („Polypill“). Herz, 43(3), 246-257. https://doi.org/10.1007/s00059-017-4554-5